OTHER NEWS - May 13, 1992
From Times Staff and Wire Reports
Prostate Drug’s Effects Studied: Merck & Co.’s experimental prostate drug Proscar can halt the progression of prostate disease, reduce the size of the enlarged gland and improve urinary flow, study results show. “This is a new therapy option for symptomatic patients who are not immediate candidates for surgery,” said Dr. Elizabeth Stoner, head of a study group, in remarks at the American Urological Assn.’s annual meeting in Washington. In February, a Food and Drug Administration advisory panel recommended approval for Proscar. Industry watchers expect marketing approval soon.
